A series of the half-sandwich Ir(III) and Rh(III) complexes [M(η5-Cpx)(dpa)X]PF6 (M = Ir for 1–6 and Rh for 7–12) containing N-(pyridin-2-yl)pyridin-2-amine (2,2′-dipyridylamine, dpa), pentamethylcyclopentadienyl (Cp*; for 1–5 and 7–11) or 1,2,3,4-tetramethyl-5-phenylcyclopentadienyl (Cpph; for 6 and 12) ring, and various monodentate ligands (X), specifically Cl− (for 1, 6, 7 and 12), Br− (for 2 and 8), I− (for 3 and 9), valproato (VP; for 4 and 10) or 4-phenylbutyrato (PB; for 5 and 11), was prepared. The complexes were thoroughly characterized by elemental analysis, IR and NMR spectroscopy and mass spectrometry. A single-crystal X-ray analysis was performed for complex [Ir(η5-Cpph)(dpa)Cl]PF6 (6), revealing a pseudo-octahedral piano-stool geometry with a bidentate N,N′-coordinated dpa ligand, a penta-hapto coordinated Cpph ring and a monodentate chlorido ligand. The crystal structure of complex 6 is stabilized by N–H⋯F, C–H⋯F, C–H⋯Cl, C–H⋯C and C⋯F non-covalent contacts. Complexes 1–12 were screened for their in vitro cytotoxicity against the A2780 human ovarian carcinoma cell line. The best-performing iridium(III) complex 6 showed markedly higher activity (IC50 = 23.5 μM) than complexes 1–3, 5, 9 and 12, whose IC50 ranged from 68.7 to 87.1 μM. Iridium(III) complex 4 and rhodium(III) complexes 7, 8, 10 and 11 were inactive against the A2780 cells in the tested concentration range (IC50 > 100.0 μM). The chlorido complexes 1, 6, 7 and 12 were studied by 1H NMR spectroscopy for their hydrolytic stability in the 20% DMF-d7/80% D2O and 20% MeOD-d4/80% D2O mixture of solvents, revealing Ir(III) complexes 1 and 6 as stable, while Rh(III) complexes 7 and 12 partially hydrolysed in the used medium. Moreover, hydrophobicity (lipophilicity) of complexes 1–12 was studied by an octanol/water partition (logP).
Read full abstract